$1.3 million in funding to support new sugar research to tackle unmet needs in national healthcare
Category: Press Release
GlycoNet start-up PanTHERA CryoSolutions receives up to $4 million investment to advance technologies in regenerative medicine
The made-in-Canada technology is revolutionizing the cryopreservation of cell and tissues.
GlycoNet scientists exploring connection between glycans in blood group and COVID-19
Pediatric cardiologist Lori West is one of six researchers from the University of Alberta receiving $2.8 million in federal funding for “exceptional opportunities” in fight against the pandemic.
GlycoNet Investigator’s new process fast-tracks drug treatments for viral infections and cancer
Discovering antiviral and anticancer drugs will soon be faster and cheaper thanks to new research from GlycoNet Investigator Dr. Robert Britton at Simon Fraser University and his international team.
PlantForm partners with GlycoNet’s Associate Scientific Director for a more effective COVID-19 serology test
The partnership, funded by NSERC Alliance Grant, will support Dr. Warren Wakarchuk’s work on the role of O-glycans in triggering immune response.
Canadian Glycomics Network investing $3.9 million in collaborative projects to address research gaps in Canadian healthcare
The fund aims to support projects that mitigate the impact of healthcare burden in Canada and contribute to better understanding of challenging diseases.
GlycoNet Investigators leverage Network project to receive $1.15M in funding for breast cancer research
Funding will enable Drs. Yves St-Pierre, David Chatenet, and Nicolas Doucet to develop a revolutionary immunotherapy against breast cancer.
GlycoNet Welcomes $16.3 Million Renewed Commitment from the Networks of Centres of Excellence for Glycomics Research
Founded in 2015, GlycoNet has been working to develop a collaborative national network to accelerate carbohydrate-based healthcare treatments, vaccine, and technologies for Canadians.
Announcement of renewed funding from NCE
The Networks of Centres of Excellence (NCE) announced today the renewed funding for five NCE networks.
Glycovax Pharma develops a vaccine against COVID-19
The biopharmaceutical company founded by GlycoNet Investigator is working to develop a semi-synthetic vaccine in the preclinical phase